Alliance Pharma Share News (APH)
APH Share
APH Share
APH Share
APH Share
APH
APH Share
APH Level 2
APH Live
APH Broker
APH Directors
APH Financial
APH
APH Short
APH
Last checked at -
Mon, 21st Mar 2022 15:22
Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Confirms that it is in talks with an unnamed third party for the acquisition of two products in the US. Should an acquisition take place the aggregate payment would come up to USD20 million at the most.
Current stock price: 111.80 pence
12-month change: up 32%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Alliance Pharma updated the market on its trading on Wednesday, reiterating that the year had started well, adding that it was continuing to see some "strong performances" from its key brands.
Read moreUK shareholder meetings calendar - next 7 days
Read moreTRADING UPDATES: HSBC announces redemption of US dollar securities
Read moreBROKER RATINGS: Morgan Stanley upgrades BT to Overweight
Read moreIndivior revamps board after accord with biggest shareholder Scopia
Read moreTRADING UPDATES: McColl's decides against payout; Luceco profit surges
Read more(Sharecast News) - Alliance Pharma reported a 4% fall in statutory revenue in its preliminary results on Tuesday, to £129.8m, although it said performance from its consumer healthcare brands was "strong", with that division now accounting for more than two thirds of group see-through revenues.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreLONDON TRADING UPDATES: Alliance Pharma 2020 Revenue Slips By 5%
Read moreIN BRIEF: Alliance Pharma Completes US Consumer Healthcare Firm Buy
Read moreIN BRIEF: Alliance Pharma Profit Plunges On Impairments
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreUK TRADING UPDATE SUMMARY: DP Eurasia Interim Sales Up On Turkey Rise
Read more
Last checked at